Cite
HARVARD Citation
Lee, N. et al. (2021). Avelumab plus standard-of-care chemoradiotherapy versus chemoradiotherapy alone in patients with locally advanced squamous cell carcinoma of the head and neck: a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial. Lancet oncology. 22 (4), pp. 450-462. [Online].